- Q3 2026 revenue of $1.6M vs $2.2M prior-year period
- Net loss of $(26.6)M or $(0.25) per share vs $(27.5)M or $(0.30) in Q3 2025
- Cash and marketable securities declined to $94.8M from $142.8M at year-end 2025
Signal #150042 · SEC 8-K
$CRBU SEC Filing Alert & Real-Time AI Stock Impact Analysis
Public T0 SEO entry. Full AI score & bullets unlock after 4 hours (VIP: instant).
FAQ: $CRBU filing catalyst
Why did $CRBU trigger an AI stock catalyst alert?
$CRBU triggered a Stock Catalyst AI alert on 2026-11-05 00:00:00 UTC for a SEC 8-K filing (AI Score: -2.5/10). Headline: Caribou Biosciences Q3 Revenue Drops to $1.6M, Cash Down to $94.8M. Key points: - Q3 2026 revenue of $1.6M vs $2.2M prior-year period - Net loss of $(26.6)M or $(0.25) per share vs $(27.5)M or $(0.30) in Q3 2025 - Cash and marketable securities declined to $94.8M from $142.8M at year-end 2025
How did $CRBU stock react after the SEC filing?
After the SEC 8-K for $CRBU, observed market reaction: T0 price $0.41. Past moves do not guarantee future results.
Where can I get real-time $CRBU SEC filing alerts?
Stock Catalyst AI pushes real-time SEC 8-K alerts for $CRBU via Telegram and the VIP Web Terminal from €10/month.
Bearish AI Sentiment (-2.5 / 10)